Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases
Ontology highlight
ABSTRACT: This study is a multicentre, prospective, randomised trial, aims to evaluate the efficacy and safety of Irinotecan Drug-Eluting Beads combined with regorafenib as the third-line treatment for a patient with colorectal cancer liver metastases. The study is planned to enrolled 126 patients failing first- and second-line standard chemotherapy treatment.
DISEASE(S): Regorafenib,Neoplasm Metastasis,Colorectal Neoplasms,Liver Neoplasms,Colorectal Cancer Liver Metastases
PROVIDER: 13484 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA